■ Atrial fibrillation: the current epidemic
Carlos A Morillo, Amitava Banerjee, Pablo Perel, David Wood, Xavier Jouven
J Geriatr Cardiol. 2017 Mar; 14(3): 195–20
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460066/
■ II diretrizes brasileiras de fibrilação atrial
Magalhães, LP et al
Arq. Bras. Cardiol., Abr 2016, vol.106, no.4, suppl.2, p.1-22
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016003100001&lng=pt&nrm=iso
■ Escores de risco de tromboembolismo e de sangramento e preditores de morte cardíaca em uma população com fibrilação atrial
Silva, Rose Mary Ferreira Lisboa da et al
Arq. Bras. Cardiol., July 2017, vol.109, no.1, p.5-13
■ Comparação de Duas Estratégias de Controle de Pressão Venosa Central na Prevenção de Fibrilação Atrial em Pós-Operatório de Revascularização do Miocárdio
Costa, Mario Augusto Cray da et al
Arq. Bras. Cardiol., Apr 2017, vol.108, no.4, p.297-303
■ Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practice guide for clinicians
Joanne M Foody
Clin Interv Aging. 2017; 12: 175–18
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279844/
■ Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study
Giuliano Ermini, Valentina Perrone, Chiara Veronesi, Luca Degli Esposti, Giuseppe Di Pasquale
Vasc Health Risk Manag. 2017; 13: 239–246
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505677/
■ Falls risk and anticoagulation for atrial fibrillation in the elderly: a delicate balance
T Hagerty, M W Rich
Cleveland Clinic Journal of Medicine 2017, vol 84 (1): 35-40
■ The state of the art: atrial fibrillation epidemiology, prevention, and treatment
D P Morin, M L Bernard, C Madias et al
Mayo Clinic Proceeding2016:1778-1810
http://www.mayoclinicproceedings.org/article/S0025-6196(16)30538-9/fulltext
■ Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Timefor a paradigm shift?
A Bayés de Luna, A Baranchuk, M Martínez-Sellés and Pyotr G Platonov
Annals of Noninvasive Electrocardiography Jan 2017
http://onlinelibrary.wiley.com/doi/10.1111/anec.12417/full
■ Atrial fibrillation in highly trained endurance athletes- description of a syndrome
F Sanchis-Gomar, C Perez-Quilis, G Lippi et al
International Journal of Cardiology 2017, vol 226: 11-20
http://www.internationaljournalofcardiology.com/article/S0167-5273(16)33071-6/fulltext
■ Atrial fibrillation and ventricular arrhythmias sex differences in electrophysiology, epidemiology, clinical presentation, and clinical outcomes
A M Gillis
Circulation 2017, vol 135: 593-608
http://circ.ahajournals.org/content/135/6/593
■ Predisposing factors for atrial fibrillation in the elderly
Kristina Wasmer, Lars Eckardt, Günter Breithardt
J Geriatr Cardiol. 2017 Mar; 14(3): 179–18
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460064/
■ Obstructive and central sleep apnea and the risk of incident atrial fibrillation in a community cohort of men and women
P Tung, Y S Levitzky, R Wang et al
Journal of the American Heart Association 2017, vol6: e00450
http://jaha.ahajournals.org/content/6/7/e004500
■ Epidemiology and management of atrial fibrillation and stroke: review of data from four European countries
Andreea D. Ceornodolea, Roland Bal, Johan L. Severens
Stroke Res Treat. 2017; 2017: 8593207
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467327/
■ Association of proteinuria and incident atrial fibrillation in patients with intact and reduced kidney function
A O Molnar, A B Eddeen, R Ducharme et al
Journal of the American Heart Association 2017, vol 6:e005685
http://jaha.ahajournals.org/content/6/7/e005685
■ Correlates of dementia and mild cognitive impairment in patients with atrial fibrillation: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)
A Alonso, D S Knopman, R F Gottesman et al
Journal of the American Heart Association 2017, vol 6:e006014
http://jaha.ahajournals.org/content/6/7/e006014
■ Normalization of testosterone levels after testosterone replacement therapyis associated with decreased incidence of atrial fibrillation
R Sharma, O A Oni, K Gupta et AL
Journal of the American Heart Association 2017, vol 6:e0048880
http://jaha.ahajournals.org/content/6/5/e004880
■ Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care
D A Lane, F Skjoth, G Y H Lip et al
Journal of the American Heart Association 2017, vol 6:e005155
http://jaha.ahajournals.org/content/6/5/e005155
■ Long-term stroke risk prediction in patients with atrial fibrillation: comparison the ABC-Strokeand CHA2DS2-VASc Scores
J M Rivera-Caravaca, V Roldán, M A Esteve-Pastor et al
Journal of the American Heart Association 2017, vol 6:e00649
http://jaha.ahajournals.org/content/6/7/e006490
■ Early life risk factors for incident atrial fibrillation in the Helsinki Birth Cohort Study
L S B Johnson, M Salonen, E Kajantie et al
Journal of the American Heart Association 2017, vol 6:e00603
http://jaha.ahajournals.org/content/6/6/e006036
■ Sex differences in the use of oral anticoagulants for atril fibrillation: A Report From the National Cardiovascular Data Registry (NCDR) PINNACLE Registry
L E Thompson, T M Maddox, L Lei et al
Journal of the American Heart Association 2017, vol 6:e005801
http://jaha.ahajournals.org/content/6/7/e005801
■ Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion
Jūratė Barysienė, Aistė Žebrauskaitė, Dovilė Petrikonytė et al
BMC Cardiovasc Disord. 2017; 17: 67
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322653/
■ Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
A John Camm, Gabriele Accetta, Giuseppe Ambrosio et al
Heart. 2017 Feb 15; 103(4): 307–314
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293840/
■ The search for atrial fibrillation and its impact on public health
A Lam, E Goulouti, L Roten
Swiss MedWkly 2017, vom 147: w14447
https://smw.ch/en/article/doi/smw.2017.14447/
■ Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
Victoria Allan, Amitava Banerjee, Anoop Dinesh Shah et al
Heart. 2017 Feb; 103(3): 210–218
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284481/
■ Comparação de Duas Estratégias de Controle de Pressão Venosa Central na Prevenção de Fibrilação Atrial em Pós-Operatório de Revascularização do Miocárdio
Costa, Mario Augusto Cray da et al
Arq. Bras. Cardiol., Apr 2017, vol.108, no.4, p.297-303
■ Colchicine to Reduce Atrial Fibrillation in the Postoperative Period of Myocardial Revascularization
Zarpelon, Camila Stuchi et al.
Arq. Bras. Cardiol., July 2016, vol.107, no.1, p.4-9
■ Use of three-dimensional computed tomography overay for real-time cryoballon ablation in atrial fibrillation reduces radiation dose and contrast dye
B O Velthuis, M Molenaar, H G R Dorman et al
Neth Heart J 2017, vol 25 (6): 388-393
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435618/
■ Left atrial appendage morphology and risk of stroke following pulmonary vein isolation for drug-refractory atrial fibrillation in low CHA2DS2Vasc risk patients
Faith R. Kelly, Robert A. Hull, Takor B. Arrey-Mbi et al
BMC Cardiovasc Disord. 2017; 17: 70
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331636/
■ Dynamic high-sensitivity troponin elevations in atrial fibrillation patients might not be associated with significant coronary artery disease
Johan Thelin, Olle Melander
BMC Cardiovasc Disord. 2017; 17: 169
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488365/
■ Design and rationale for the WARFA Trial: a randomized controlled cross-over Trial testing the therapeutic equivalence of branded and generic warfarin in atrial fibrillation patients in Brazil
Carolina Gomes Freitas, Michael Walsh, Álvaro Nagib Atallah
BMC Cardiovasc Disord. 2017; 17: 148.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463418/
■ Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation
Expert consensus paper of the European Society of Cardiology Working Group on Thrombosis
S Halvorsen, R F Storey, B Rocca et al
Eur Heart J 2017, vol 38 (19)1455-1462
■ Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with ininterrupted rivaroxaban
- Tsyganov, A. Shapieva, V. Sandrikov et al
BMC Cardiovasc Disord. 2017; 17: 171
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492399/
■ Catheter ablation in patients with persistent atrial fibrillation
Paulus Kirchhof, Hugh Calkins
Eur Heart J. 2017 Jan 1; 38(1): 20–26.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353871
■ Atrial fibrillation, cognitive impairment and neuroimaging
Jonathan Graff-Radford, Malini Madhavan, Prashanthi Vemuri et al
Alzheimers Dement. 2016 Apr; 12(4): 391–398
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841716/
■ Atrial fibrillation in women: treatment
Darae Ko, Faisal Rahman, Maria A. P. Martins et al
Nat Rev Cardiol. 2017; 14(2): 113–124
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520636/
■ Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
Niklas Höglund, Carin Sahlin, Milos Kesek, Steen M. Jensen, Karl A. Frankli
Ups J Med Sci. 2017 vol 122(2): 114–11
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441371/
■ Symptoms in atrial fibrillation: a contemporary review and future decisions
Steven T Heidt, Anna Kratz, Kayvan Najarian et al
J Atr Fibrillation. 2016 Jun-Jul; 9(1): 1422